Alaunos Therapeutics Inc. (TCRT) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Alaunos Therapeutics Inc.

    NASDAQ: TCRT · Real-Time Price · USD
    2.56
    -0.07 (-2.66%)
    At close: Oct 03, 2025, 3:59 PM
    2.55
    -0.39%
    Pre-market: Oct 06, 2025, 04:01 AM EDT

    Alaunos Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 1.09M 6.06M 39.06M 76.05M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 n/a n/a 542K 673K
    Receivables
    		 5K 1K 4K 1.11M
    Inventory
    		 n/a n/a 13.94M n/a
    Other Current Assets
    		 1.66M 2.2M 799K 1.67M
    Total Current Assets
    		 2.75M 8.26M 53.8M 78.83M
    Property-Plant & Equipment
    		 n/a 2K 10.6M 15.36M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 n/a 2K 11.14M 16.03M
    Total Assets
    		 2.75M 8.26M 64.94M 94.86M
    Account Payables
    		 516K 616K 1.39M 1.37M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a 17.32M 8.6M
    Other Current Liabilities
    		 n/a 1.3M 3.74M 3.65M
    Total Current Liabilities
    		 692K 1.96M 24.17M 16.04M
    Long-Term Debt
    		 n/a n/a n/a 16.25M
    Other Long-Term Liabilities
    		 n/a n/a 28K -1K
    Total Long-Term Liabilities
    		 n/a n/a 2.22M 20.77M
    Total Liabilities
    		 692K 1.96M 26.38M 36.81M
    Total Debt
    		 n/a n/a 19.51M 29.36M
    Book Value
    		 2.06M 6.31M 38.55M 58.06M
    Book Value Per Share
    		 1.29 3.94 26.63 40.62
    Common Stock
    		 2K 16K 240K 216K
    Retained Earnings
    		 -920.45M -915.77M -880.63M -842.85M
    Comprehensive Income
    		 n/a n/a n/a n/a
    Shareholders Equity
    		 2.06M 6.31M 38.55M 58.06M
    Total Investments
    		 n/a n/a n/a n/a

    Add to Watchlist